| 注册
首页|期刊导航|中国药物经济学|强化阿托伐他汀钙治疗高龄患者CTO病变的临床研究

强化阿托伐他汀钙治疗高龄患者CTO病变的临床研究

黄振坚 覃善都 何世安 雷斌 刘新丁

中国药物经济学Issue(1):195-197,3.
中国药物经济学Issue(1):195-197,3.

强化阿托伐他汀钙治疗高龄患者CTO病变的临床研究

Clinical Study on Intensive Atorvastatin Calcium in the Treatment of CTO Lesions in Elderly Patients

黄振坚 1覃善都 1何世安 1雷斌 1刘新丁1

作者信息

  • 1. 解放军第303医院干部病房,广西南宁 530021
  • 折叠

摘要

Abstract

Objective Study on intensive atorvastatin calcium (vertical Puto) clinical efficacy in elderly patients with coronary heart disease, treatment of CTO lesions in safety.Methods 180 cases in elderly CTO patients were divided into three groups, al 60 cases, the control group were given conventional other Ting drug and stent implantation, the routine group were given 20mg daily atorvastatin calcium and stent implantation, strengthen the group were given atorvastatin 40mg daily intensive and no stent implantation, patients aggregation, to observe the three groups of patients with clinical curative effect, safety. Results 5 years of folow-up, patients in strengthen the group had clinical efficiency (85.00%) than in the control group (63.33%), control group (68.33%) was obviously improved, and the risk of cardiovascular events incidence rate (21.67%) than in the other two groups (50.00%, 38.33%) were significantly decreased, with a significant difference (P<0.05), and no significant adverse reaction.Conclusion Intensive atorvastatin(Lipitor)patients can significantly improve the clinical efficiency and reduce cardiovascular risk in patients with coronary heart disease events in treatment of CTO lesions in elderly patients, can survive for patients with elevated.

关键词

阿托伐他汀钙/冠心病/CTO病变

Key words

Atorvastatin calcium/Coronary disease/CTO lesions

分类

医药卫生

引用本文复制引用

黄振坚,覃善都,何世安,雷斌,刘新丁..强化阿托伐他汀钙治疗高龄患者CTO病变的临床研究[J].中国药物经济学,2014,(1):195-197,3.

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文